Semler Scientific (NASDAQ: SMLR) reported Q2 EPS of $0.00, $0.72 worse than the analyst estimate of $0.72. Revenue for the quarter came in at $14.5 million versus the consensus estimate of $14.2 million.

For earnings history and earnings-related data on Semler Scientific (SMLR) click here.